Ernexa Therapeutics ERNA Cash Flow Statement (2010-2026)

NASDAQ ERNA
$2.11 0.00 (-0.22%)
As of: Oct 22, 2026 · 2:46 PM EDT
Reported Financials

Ernexa Therapeutics Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Ernexa Therapeutics reported cash from operations of -$4.12M and free cash flow of -$4.12M for the quarter ended Jun 2026, down 62.6% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-85.99M-7.95M-9.38M-3.40M-7.32M-4.49M-5.42M-4.51M-5.59M-6.15M-6.65M-5.53M-26.60M-5.76M-8.20M-3.14M-1.24M-1.50M-5.51M-4.01M
Depreciation and DepletionDep. & Depletion
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.25M0.45M0.47M1.23M3.11M
Depreciation & Amortization (CF)Dep. & Amort.
0.03M0.02M0.04M0.07M0.04M0.02M0.02M0.02M0.02M0.02M0.04M0.04M0.04M0.02M0.02M0.02M0.02M0.01M0.01M0.01M
Share-based CompensationStock Comp.
1.73M1.93M1.18M0.88M0.48M0.40M0.69M0.21M0.17M0.17M0.28M0.42M0.41M0.41M0.50M0.37M0.29M0.33M0.31M0.32M
Cash from Discontinued OperationsCash from Discont. Ops
Gains from Sales and DivestituresGains Divest
0.37M-0.13M0.00M0.00M0.50M
Asset Writedowns and ImpairmentWritedown
5.99M0.01M2.04M
Cash from Restructuring
Other non-cash itemsOther Non-Cash
0.07M0.10M0.02M-9.39M-0.94M-0.23M0.09M-0.31M-0.02M0.52M0.75M-0.24M21.61M1.98M0.05M0.04M-0.73M-0.01M0.08M-0.04M
Change in Working Capital
Change in ReceivablesChange Receivables
0.66M
Change in Accured ExpensesChange Accured Exp.
-2.06M-0.29M0.49M1.81M-0.92M0.66M-1.77M1.31M1.55M-4.00M0.46M1.09M-0.79M-0.58M-0.10M-0.37M0.30M0.22M0.76M-0.39M
Change in TaxesChange Taxes
Change in Other Operating AssetsOther Assets Change
-0.37M0.37M-0.22M0.94M0.42M-0.05M-1.01M1.31M3.10M-4.38M-0.88M-0.05M-0.53M0.16M-0.33M0.18M-0.10M0.91M-0.43M-0.04M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.87M-0.27M-0.31M1.34M2.79M-1.05M-0.72M-0.04M0.47M0.08M-0.36M0.61M-3.02M-0.70M-0.05M0.09M-0.12M0.64M-0.48M-0.13M
Other Working Capital ChangesOther WC Changes
-0.50M-0.65M-0.09M0.40M2.37M-1.00M0.29M-1.35M-2.62M4.47M0.52M0.66M-2.49M-0.85M0.28M-0.10M-0.02M-0.27M-0.05M-0.10M
Cash from OperationsCash from Ops.
-6.42M-6.83M-5.43M-3.99M-6.12M-5.44M-6.05M-3.87M-5.83M-4.66M-3.75M-2.26M-6.29M-3.55M-2.07M-2.53M-1.30M-1.12M-2.30M-4.12M
Investing Activities
Capital ExpendituresCapex
22.86M0.15M0.05M0.19M0.04M0.02M0.02M0.10M0.25M0.02M0.02M0.00M0.00M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.10M0.20M0.00M
Change in Property, Plant and EquipmentChange in PP&E
-22.86M-0.15M-0.05M-0.09M-0.04M0.18M-0.02M-0.10M-0.25M-0.02M-0.02M0.00M0.00M
Change in IntangiblesChange Intangibless
Divestments
Net of Acquisitions & DivestmentsNet Acquisitions
Sale and Maturity of InvestmentsInvestments Sold
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-22.86M-0.15M-0.05M-0.09M-0.04M0.13M-0.02M-0.10M-0.25M-0.02M-0.02M0.00M0.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
9.29M1.41M3.89M2.25M
Long-Term Debt RepaymentsLT Debt Repayment
0.41M0.00M0.00M1.50M
Non-Current Debt
-0.41M0.00M0.00M7.79M1.41M3.89M2.25M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.41M0.00M0.00M7.79M1.41M3.89M2.25M
Change in Capital Stock
Common Stock IssuedStock Issued
11.99M7.71M0.00M4.93M0.03M10.50M
Shares Repurchased
0.94M
Net Shares Issued and RepurchasedNet Shares Issued
11.99M7.71M0.00M4.93M0.03M9.56M
Net Equity Issued and RepurchasedNet Equity Issued
11.99M7.71M0.00M4.93M0.03M9.56M
Dividend Payments
Dividends Paid - PreferredDiv. Paid (Pref.)
0.01M0.01M0.01M
Dividends Paid - Common and PrefferdDiv Paid (Total)
0.01M0.01M0.01M
Other financing activitiesOther financing
0.00M-0.18M-0.08M-0.02M-0.01M-0.14M0.00M
Cash from Financing ActivitiesCash from Financing
3.50M-0.42M11.99M-0.01M0.01M7.59M0.31M8.54M7.70M1.39M-0.02M3.89M1.01M2.25M4.93M0.03M9.56M0.01M
Additional items
Exchange Rate EffectFX Effect
Change in Cash
-25.78M-7.40M6.52M-4.09M-6.15M2.29M-6.05M-3.56M2.71M3.02M-2.46M-2.53M-2.42M-2.54M0.19M2.40M-1.27M-1.16M7.29M-4.15M
Ending Cash Balance
24.38M16.99M23.50M19.41M13.25M15.54M9.49M5.93M8.65M11.67M9.21M6.68M4.26M1.73M1.92M4.32M3.05M1.88M9.18M5.03M
Free Cash FlowFCF
-29.28M-6.98M-5.48M-4.18M-6.16M-5.46M-6.05M-3.87M-5.83M-4.68M-3.85M-2.51M-6.30M-3.55M-2.07M-2.53M-1.30M-1.13M-2.30M-4.12M
Net Cash FlowNCF
-25.78M-7.40M6.52M-4.09M-6.15M2.29M-6.05M-3.56M2.71M3.02M-2.46M-2.53M-2.42M-2.54M0.19M2.40M-1.28M-1.13M7.26M-4.11M
Interest Paid
0.01M0.21M0.00M0.01M0.01M0.01M0.00M0.01M0.01M0.01M0.04M0.00M0.00M0.00M
Income Taxes PaidTaxes Paid
0.00M0.01M0.01M0.00M0.00M0.00M

Ernexa Therapeutics Cash Flow Statement API

Pull Ernexa Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ERNA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY